Bacterial Infections  >>  Nuvocid (oritavancin)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuvocid (oritavancin) / Melinta Therap, Menarini
NCT03159403: A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting

Completed
N/A
325
US
Oritavancin, Orbactiv®
Melinta Therapeutics, Inc.
Gram-Positive Bacterial Infections
02/18
03/18

Download Options